Fig. 9From: Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancerValidation of the efficacy of the drugs predicted by CMap database. a Flowchart of the drug validation process. b Risk score of pancreatic cancer cell lines and selected cell lines (red box). c Drug sensitivity curves and IC50 values of cell lines in the low-risk group. d Drug sensitivity curves and IC50 values of cell lines in the high-risk groupBack to article page